The FDA issued a Class I recall — the most serious recall classification — for some of Medtronic’s cardiac resynchronization therapy and implantable cardioverter defibrillators. Here are four things ...

WASHINGTON (Reuters) - Patient injury reports for the tiny wires used with Medtronic's implantable heart devices jumped dramatically in the past year, a consumer group said on Tuesday, a day after the ...

CHICAGO (Reuters) - Medtronic Inc said on Tuesday a study of device therapy in patients with mild heart failure missed its primary goal on a measure of disease progression, but some patients saw their ...

More and more medical studies show that heart issues in women are not only underdiagnosed but should be treated differently. A study Medtronic designed to test its Evolut TAVR (transcatheter aortic ...

For a person with a pacemaker or implantable defibrillator, a weekend or evening trip to the emergency room or urgent care can become an hours-long slog of waiting for the "expert" to show up.

Medtronic is cautioning physicians to be careful when using a popular new heart valve after 19 patients died from severe blood vessel trauma caused by the device, reports the Star Tribune. Minneapolis ...

Medtronic (NYSE: MDT) today announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform.

Boston Scientific raised its annual profit forecast on Wednesday, after beating third-quarter profit estimates on strong ...

Medtronic (NYSE:MDT) strengthens its healthcare offerings. Key sectors of Medtronic show growth. S&P 500 futures reflects trends in healthcare. Medtronic plc (NYSE:MDT) is a global leader in medical ...